Ligand · IVO
IVO · (5~{S},6~{R},7~{S},8~{S})-6,7,8-tris(oxidanyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid
IVO, (5~{S},6~{R},7~{S},8~{S})-6,7,8-tris(oxidanyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid (C8 H10 N2 O5, 214.2 g/mol), in the MolNFT structures on GenesisL1: bound in 1 record (1 PDB entry). Every binding site with its…
- Component
- IVO
- Formula
- C8 H10 N2 O5
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
IVO in 1 structure; the first of them:
- 7YJC · Crystal structure of Human HPSE1 in complex with inhibitor · IVO A601 · binds ASN224, GLU225, HIS296, TYR298, GLU343, ALA347, TYR348, GLY349 and 7 more
Residues it binds most
GLY 1, TYR 1, GLU 1, ALA 1, ASN 1, ASP 1, GLN 1, HIS 1, THR 1 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.